TNFRSF19 and tuberous sclerosis: Xu et al. confirmed that Nogo-A might be involved in the development of tuberous sclerosis syndrome and focal type 2b cortical disease or seizures by mediating the NgR/LINGO-1/TROY signal transduction pathway [55].